PMID- 38196685 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20240210 IS - 2690-7097 (Electronic) IS - 2690-7097 (Linking) VI - 4 IP - 4 DP - 2023 Dec TI - A Novel Provider Education Module to Enhance Detection of Alpha-1 Antitrypsin Deficiency. PG - 490-501 LID - 10.34197/ats-scholar.2023-0028OC [doi] AB - BACKGROUND: Alpha-1 antitrypsin deficiency (AATD) is the most common genetic risk factor for early-onset emphysema. However, AATD continues to be underrecognized and underdiagnosed. Provider awareness about AATD, concerns with testing costs, and limited understanding about therapeutic options contribute to its underdiagnosis. We hypothesized that provider education would improve awareness of AATD and improve screening. OBJECTIVE: To evaluate the impact of a targeted provider education module on AATD screening. METHODS: We developed a web-based education module to address barriers to screening for AATD, deployed the education module using the Medscape Education platform, assessed perceived healthcare provider confidence in AATD screening, and conducted a prospective pre and postintervention study of AATD testing practices at a high-volume academic outpatient subspecialty pulmonary clinic. RESULTS: A total of 11,385 healthcare providers, including eight pulmonologists at our institution, completed the web-based education module. Confidence in identifying patients at high risk for AATD improved after completing the module ("not confident" in AATD screening was 7.7% postintervention compared with 19.4% preintervention). The rate of screening patients at high risk for AATD improved more than twofold (AATD screening rate 9.7% preintervention vs. 20.4% postintervention; P = 0.004). Among patients screened for AATD in our cohort, 27.2% had a genotype/phenotype or low alpha-1 antitrypsin concentration consistent with AATD. CONCLUSION: Targeted healthcare provider education can improve the confidence in testing for AATD. Improvements in provider confidence corresponded to improvements in AATD screening in a subspecialty pulmonary clinic. More than one-fourth of screening tests suggested AATD, underpinning the value of testing in high-risk individuals. CI - Copyright (c) 2023 by the American Thoracic Society. FAU - Schumacher, Ross C AU - Schumacher RC AUID- ORCID: 0000-0002-7577-3599 AD - Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, and. AD - Lung Health Center, University of Alabama at Birmingham, Birmingham, Alabama. FAU - Chiu, Chia-Ying AU - Chiu CY AD - Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, and. AD - Lung Health Center, University of Alabama at Birmingham, Birmingham, Alabama. FAU - Lubarda, Jovana AU - Lubarda J AD - Medscape, LLC, New York, New York; and. FAU - Aboulsaoud, Pakinam AU - Aboulsaoud P AD - Medscape, LLC, New York, New York; and. FAU - Bomberger, Jennifer AU - Bomberger J AD - Medscape, LLC, New York, New York; and. FAU - Wells, J Michael AU - Wells JM AUID- ORCID: 0000-0001-9612-5454 AD - Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, and. AD - Lung Health Center, University of Alabama at Birmingham, Birmingham, Alabama. AD - Birmingham Veterans Affairs Healthcare System, Birmingham, Alabama. LA - eng GR - R01 HL148215/HL/NHLBI NIH HHS/United States PT - Journal Article DEP - 20230817 PL - United States TA - ATS Sch JT - ATS scholar JID - 101774447 CIN - doi: 10.34197/ats-scholar.2023-0128ED PMC - PMC10773490 OTO - NOTNLM OT - alpha-1 antitrypsin deficiency OT - chronic obstructive pulmonary disease OT - education EDAT- 2024/01/10 06:42 MHDA- 2024/01/10 06:43 PMCR- 2023/08/17 CRDT- 2024/01/10 03:40 PHST- 2023/02/16 00:00 [received] PHST- 2023/06/22 00:00 [accepted] PHST- 2024/01/10 06:43 [medline] PHST- 2024/01/10 06:42 [pubmed] PHST- 2024/01/10 03:40 [entrez] PHST- 2023/08/17 00:00 [pmc-release] AID - 10.34197/ats-scholar.2023-0028OC [doi] PST - epublish SO - ATS Sch. 2023 Aug 17;4(4):490-501. doi: 10.34197/ats-scholar.2023-0028OC. eCollection 2023 Dec.